In vitro characterization of calcium phosphate biomaterial loaded with linezolid for osseous bone defect implantation

Journal of Biomaterials Applications

Volumn 26, Issue 7, 2012, Pages 811-828

  Gautier, Hélène ^a,b   Plumecocq, Adrien ^a   Amador, Gilles ^b   Weiss, Pierre ^a   Merle, Christian ^a,b   Bouler, Jean Michel ^a  

^a Universite de Nantes   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

antibiotic; biomaterials; calcium phosphate; drug delivery system; linezolid

Indexed keywords

ANTI-BACTERIAL ACTIVITY; BONE DEFECT; BONE INFECTION; BONE SUBSTITUTES; CALCIUM-DEFICIENT APATITES; DRUG DELIVERY SYSTEM; GRAM-POSITIVE BACTERIUM; IN-VITRO; LINEZOLID; MERCURY POROSIMETRY; METHICILLIN; MODE OF ACTION; NMR ANALYSIS; OXAZOLIDINONES; STAPHYLOCOCCUS AUREUS; THERAPEUTIC TREATMENTS; WET GRANULATION;

ANTIBIOTICS; APATITE; BACTERIA; BIOLOGICAL MATERIALS; BIOMATERIALS; CALCIUM PHOSPHATE; DRUG DELIVERY; GRANULATION; MERCURY (METAL); SCANNING ELECTRON MICROSCOPY;

BONE;

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; APATITE; BIOMATERIAL; CALCIUM PHOSPHATE; DRUG CARRIER; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ARTICLE; CHEMISTRY; HUMAN; OSTEOMYELITIS;

ACETAMIDES; ANTI-INFECTIVE AGENTS; APATITES; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; DRUG CARRIERS; HUMANS; OSTEOMYELITIS; OXAZOLIDINONES;

EID: 84859094312     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328210381535     Document Type: Article

References (37)

1. Chai F., Hornez J-C., Blanchemain N., Neut C., Descamps M., Hildebrand H.F. Antibacterial Activation of Hydroxyapatite (HA) with Controlled Porosity by Different Antibiotics. Biomol. Eng.. 2007 ; 24: 510-514 (Pubitemid 350123182)
2. Alvarez H., Castro C., Moujir L., et al. Efficacy of Ciprofloxacin Implants in Treating Experimental Osteomyelitis. J. Biomed. Mater. Res. Part B Appl. Biomater.. 2007 ; 85B: 93-104 (Pubitemid 351458232)
3. Nandi S.K., Kundu B., Ghosh S.K., et al. Cefuroxime-impregnated Calcium Phosphates as an Implantable Delivery System in Experimental Osteomyelitis. Ceram. Int.. 2009 ; 35: 1367-1376
4. Efstathopoulos N., Giamarellos-Bourboulis E., Kanellakopoulou K., et al. Treatment of Experimental Osteomyelitis by Methicillin Resistant Staphylococcus Aureus with Bone Cement System Releasing Grepafloxacin Injury. Int. J. Care Injured. 2008 ; 39: 1384-1390
5. Hesaraki S., Nemati R. Cephalexin-loaded Injectable Macroporous Calcium Phosphate Bone Cement. J. Biomed. Mater. Res. Part B Appl. Biomater.. 2009 ; 89: 342-352
6. Hofmann M.P., Mohammed A.R., Perrie Y., Gbureck U., Barralet J.E. High-Strength Resorbable Brushite Bone Cement with Controlled Drug-releasing Capabilities. Acta Biomater.. 2009 ; 5: 43-49
7. Sasaki S., Ishii Y. Apatite Cement Containing Antibiotics: Efficacy in Treating Experimental Osteomyelitis. J. Orthop. Sci.. 1999 ; 4: 361-369 (Pubitemid 29506002)
8. Bohner M., Lemaître J., Van Landuyt P., Zambelli P-Y., Merkle H.P., Gander B. Gentamicin-loaded Hydraulic Calcium Phosphate Bone Cement as Antibiotic Delivery System. J. Pharm. Sci.. 1997 ; 86: 565-572 (Pubitemid 27203403)
9. LeGeros R.Z. Calcium Phosphate-based Osteoinductive Materials. Chem. Rev.. 2008 ; 108: 4742-4753
10. Sudo A., Hasegawa M., Fukuda A., Uchida A. Treatment of Infected Hip Arthroplasty with Antibiotic Impregnated Calcium Hydroxyapatite. J. Arthroplasty. 2008 ; 23: 145-150 (Pubitemid 350299734)
11. Krisanapiboon A., Buranapanitkit B., Oungbho K. Biocompatability of Hydroxyapatite Composite as a Local Drug Delivery System. J. Orthop. Surg.. 2006 ; 14: 315-318
12. Saito T., Takeuchi R., Hirakawa K., et al. Slow-releasing Potential of Vancomycin-Loaded Porous Hydroxyapatite Blocks Implanted into MRSA Osteomyelitis. J. Biomed. Mater. Res. Part B Appl. Biomater.. 2002 ; 63: 45-251
13. Ebner D.C., Culhane J.C., Winkelman T.N., Haustien M.D., Ditty J.L., Ippoliti J.T. Synthesis of Novel Oxazolidinone Antimicrobial Agents. Bioorg. Med. Chem.. 2008 ; 16: 2651-2656 (Pubitemid 351380920)
14. Diekema D.J., Jones R.N. Oxazolidinone Antibiotics. New Drug Classes. Lancet. 2001 ; 358: 1975-1982 (Pubitemid 34072884)
15. Jacqueline C., Caillon J., Potel G. Linézolide, Données Récentes Expérimentales In Vitro et In Vivo. Antibiotiques. 2005 ; 7: 225-233
16. Kutscha-Lissberg F., Hebler U., Muhr G., Köller M. Linezolid Penetration into Bone and Joint Tissues Infected with Methicillin-Resistant Staphylococci. Antimicrob. Agents Chemother.. 2003 ; 47: 3964-3966 (Pubitemid 37485016)
17. Guillemot D. Consommation d'antibiotiques et Résistance des Bactéries. Pour la Science. 2005 ;:
18. Weigelt J., Kaafarani H.M., Itani K.M., Swanson R.N. Linezolid Eradicates MRSA Better than Vancomycin from Surgical-site Infections. Am. J. Surg.. 2004 ; 188: 760-766
19. Bassetti M., Di Biagio A., Cenderello G., et al. Linezolid Treatment of Prosthetic Hip Infections due to Methicillin-resistant Staphylococcus aureus (MRSA). J. Infect.. 2001 ; 43: 148-157 (Pubitemid 33077064)
20. Adembri C., Fallani S., Cassetta M.I., et al. Linezolid Pharmacokinetic/Pharmacodynamic Profile in Critically Ill Septic Patients: Intermittent versus Continuous Infusion. Int. J. Antimicrob. Agents. 2008 ; 31: 122-129
21. Darley E.S.R., MacGowan A.P. Antibiotic Treatment of Gram-positive Bone and Joint Infections. J. Antimicrob. Chemother.. 2004 ; 53: 928-935 (Pubitemid 38811422)
22. Falagas M.E., Siempos I.I., Papagelopoulos P.J., Vardakas K.Z. Linezolid for the Treatment of Adults with Bone and Joint Infections. Int. J. Antimicrob. Agents. 2007 ; 29: 233-239 (Pubitemid 46240739)
23. Lovering A.M., Zhang J., Bannister G.C., et al. Penetration of Linezolid into Bone, Fat, Muscle and Haematoma of Patients Undergoing Routine Hip Replacement. J. Antimicrob. Chemother.. 2002 ; 50: 73-77 (Pubitemid 34785257)
24. Rana B., Butcher I., Grigoris P., Murnaghan C., Seaton R.A., Tobin C.M. Linezolid Penetration into Osteo-articular Tissues. J. Antimicrob. Chemother.. 2002 ; 50: 747-750 (Pubitemid 35331696)
25. Akpabie A., Naga H., Giraud K., Al Rahiss R., Nadai S. Resistance to Linezolid in Staphylococcus Aureus before its Release. Pathol. Biol.. 2004 ; 52: 493-496 (Pubitemid 39311412)
26. Liao C-H., Tseng S-P., Fang C-T., Teng L-J., Hsueh P-R. First Linezolid- and Vancomycin-resistant Enterococcus Faecium Strain in Taiwan. J. Antimicrob. Chemother.. 2005 ; 55: 598-599 (Pubitemid 40542611)
27. Tsiodras S., Gold H.S., Sakoulas G., et al. Linezolid Resistance in a Clinical Isolate of Staphylococcus Aureus. Research Letters. Lancet. 2001 ; 358: 207-208 (Pubitemid 32718546)
28. Gautier H., Merle C., Auget J-L., Daculsi G. Isostatic Compression, a New Process for Incorporating Vancomycin into Biphasic Calcium Phosphate Comparison with a Classical Method. Biomaterials. 2000 ; 21: 243-249
29. Faucheux C., Verron E., Soueidan A., et al. Controlled Release of Bisphosphonate from a Calcium Phosphate Biomaterial Inhibits Osteoclastic Resorption In Vitro. J. Biomed. Mater. Res. A. 2009 ; 89: 46-56
30. Kimakhe S., Bohic S., Larrose C., et al. Biological Activities of Sustained Polymyxin B Release from Calcium Phosphate Biomaterial Prepared by Dynamic Compaction: An In Vitro Study. J. Biomed. Mater. Res.. 1999 ; 47: 18-27 (Pubitemid 29344965)
31. Till M., Wixson R.L., Pertel P.E. Linezolid Treatment for Osteomyelitis Due to Vancomycin-Resistant. Enterococcus faecium,. Clin. Infect. Dis.. 2002 ; 34: 1412-1414 (Pubitemid 34507953)
32. Nam J.R., Kim M.S., Lee C.H., Whang D.H. Linezolid Treatment for Osteomyelitis due to Staphylococcus Epidermidis with Reduced Vancomycin Susceptibility. J. Korean Neurosurg. Soc.. 2008 ; 43: 307-310
33. Oussedik S.I.S., Haddad F S. The Use of Linezolid in the Treatment of Infected Total Joint Arthroplasty. J. Arthroplasty. 2008 ; 23: 273-278 (Pubitemid 351226503)
34. Ormos Z.D Handbook of Powder Technology, Powder Technology and Pharmaceutical Processes. Williams J.C Allen T., ed. London, New York, Tokyo: Elsevier ; 1994: 359-376.
35. Le Ray A-M., Gautier H., Laty M-K., et al. In Vitro and In Vivo Bactericidal Activities of Vancomycin Dispersed in Porous Biodegradable Poly(-caprolactone) Microparticles. Antimicrob. Agents and Chemother.. 2005 ; 49: 3025-3027 (Pubitemid 40917633)
36. Gautier H., Daculsi G., Merle C. Association of Vancomycin and Calcium Phosphate by Dynamic Compaction: In Vitro Characterization and Microbiological Activity. Biomaterials. 2001 ; 22: 2481-2487 (Pubitemid 32706449)
37. Fernandez-Roblas R., Adames H., Martín-de-Hijas N.Z., Almeida D.G., Gadea I., Esteban J. In Vitro Activity of Tigecycline and 10 Other Antimicrobials against Clinical Isolates of the Genus Corynebacterium. Int. J. Antimicrob. Agents. 2009 ; 33: 453-455